Health ❯ Medicine

Pharmaceuticals

Weight Loss Drug Development Weight Loss Drugs Clinical Trials Diabetes Acetaminophen Pain Relief Drug Safety Drug Approval Cannabis Over-the-Counter Medications Antibiotics Abortion Pregnancy Side Effects GLP-1 Drugs Obesity Weight Loss Medications Cancer Treatment Pain Management Paracetamol Pain Relievers Weight-loss Drugs Erectile Dysfunction Diabetes Treatment Weight-Loss Drugs Obesity Treatments Insulin Weight Management Drug Trials Obesity Treatment Prescription Drugs Aspirin Abortion Drugs Obesity Drugs Contraceptives Drug Side Effects Supplements Veterinary Medicine Semaglutide Abortion Pill Autism Drug Pricing Vaccines Antiviral Drugs Oncology Recalls Biotechnology Neurology Over-the-Counter Drugs Counterfeit Drugs Biopharma Alzheimer's Disease Diabetes Medication FDA Approval Dietary Supplements Cancer Cosmetic Procedures Asthma Adverse Effects Doping Substances Medication Abortion Medication Safety Regulations Weight-loss drugs Mifepristone Vaccine Development Drug Use HIV/AIDS Contraception Inhalers Drug Regulation Painkillers Drug Discovery Product Safety Abortion-Inducing Drugs Diabetes Medications HIV Prevention Drug Formulation Therapies Birth Control Opioids Eye Care Allergy Treatment Safety FDA Regulations Contamination GLP-1 Agonists Kidney Disease FDA approval Viagra Demand Forecasting Drug Evaluation Clonazepam Pfizer Amyloid Plaques Allergy Medications Potassium Chloride Experimental Drugs Drug Approvals

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Pfizer plans 10 phase 3 trials this year to test higher monthly doses suggested by the phase 2 data.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Federal Move to Reclassify Cannabis Advances as Senate Republicans Seek to Block It

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Oprah's GLP-1 Push and Serena Williams' Ro Tie Raise New Questions Over Celebrity Weight-Loss Deals

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

FDA-Cleared Wegovy Pill Becomes First Oral GLP-1 for Weight Loss

Trump Orders DOJ to Expedite Marijuana Rescheduling to Schedule III

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Terry Dubrow Claims GLP-1 Weight Loss Can Produce an 'Ozempic Penis'

Low-Dose Colchicine Lowers Heart Attack and Stroke Risk in Heart Disease, Cochrane Review Finds

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid